# Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis

> **NCT05121870** · PHASE2 · UNKNOWN · sponsor: **Beijing 302 Hospital** · enrollment: 240 (estimated)

## Conditions studied

- Decompensated Cirrhosis

## Interventions

- **BIOLOGICAL:** UC-MSCs
- **BIOLOGICAL:** Saline containing 1% Human serum albumin（solution without UC-MSCs）

## Key facts

- **NCT ID:** NCT05121870
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2021-11-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05121870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05121870, "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05121870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*